Bus depots show support for Movember

02 Dec 2015

Fifteen Movember supporters from Stagecoach North East’s Sunderland bus depot have shaved off their collective moustaches after raising money for charity throughout the month.

At the start of November, engineers and other members of staff from the local bus operator threw away their razors and started growing a series of impressive moustaches, with some colourful and wacky results!

The fifteen men were taking part in the national Movember campaign in order to raise money for the Institute of Cancer Research and Prostate Cancer Research, an initiative which is well supported and proves very popular at the depot each year.

The group of hirsute men have managed to raise over £730 so far, with more money to come in, and should reach over £1,000 in total. Family and friends of the employees were also very generous in supporting the ‘Mo bros’, with three staff raising over £150 each and bus inspector, Michael Ross, raising £272.

Tony Smith, 54, from Seaham, who took part and dyed his beard and hair blue in support, said: “The Movember campaign is a part of our charity calendar now and it’s become a challenge for the guys. I think we impressed the rest of the depot and our friends and family with our efforts and raised a great amount for such a worthy cause. There certainly were some smiles with my blue beard, plus Mohicans and glittery facial hair!”

Phil Medlicott, Managing Director, Stagecoach North East, said: “We were thrilled to get behind the Movember team for another year. It’s such a visual fundraising effort and hopefully it brightened up the journey for our customers!

“We always encourage and support those members of staff who want to give something back to the community and the Movember team just one group of a large number at the Sunderland depot who raise money for both national and regional charities.”

Every November thousands of men across the UK take part in Movember. The money raised in the UK supports the two primary male specific cancers - prostate and testicular cancer.